南方医科大学学报2016，Vol.36Issue(8)：1163-1164,2.DOI:10.3969/j.issn.1673-4254.2016.08.26
Daclatasvir联合asunaprevir治疗基因1b型慢性丙型肝炎1例报告
Combined therapy with daclatasvir plus asunaprevir for chronic hepatitis C genotype 1b:a case report
皮赛男 1陈友鹏1
作者信息
- 1. 暨南大学附属第一医院感染科，广东 广州 510630
- 折叠
摘要
Abstract
The combination therapy with daclatasvir and asunaprevir can achieve a high sustained viral response rate against hepatitis C virus (HCV) genotype 1, but so far this regimen has not been reported in the treatment of Chinese patients with chronic hepatitis C (CHC) genotype 1b. Here we report a case of CHC genotype 1b in a 44-year-old female chinese patient who was treated with this regimen for 24 weeks. The patient showed sustained viral response after the treatment and was clinically cured. During the treatment, the patient experienced a transient elevation of serum total bilirubin accompanied by lowered hemoglobin fluctuating between 100 and 110 g/L.关键词
daclatasvir/asunaprevir/慢性丙型肝炎/基因1b型/治疗Key words
daclatasvir/asunaprevir/chronic hepatitis C/genotype 1/therapy引用本文复制引用
皮赛男,陈友鹏..Daclatasvir联合asunaprevir治疗基因1b型慢性丙型肝炎1例报告[J].南方医科大学学报,2016,36(8):1163-1164,2.
